170 related articles for article (PubMed ID: 29335871)
1. Validation of tautomeric and protomeric binding modes by free energy calculations. A case study for the structure based optimization of D-amino acid oxidase inhibitors.
Orgován Z; Ferenczy GG; Steinbrecher T; Szilágyi B; Bajusz D; Keserű GM
J Comput Aided Mol Des; 2018 Feb; 32(2):331-345. PubMed ID: 29335871
[TBL] [Abstract][Full Text] [Related]
2. Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.
Szilágyi B; Kovács P; Ferenczy GG; Rácz A; Németh K; Visy J; Szabó P; Ilas J; Balogh GT; Monostory K; Vincze I; Tábi T; Szökő É; Keserű GM
Bioorg Med Chem; 2018 May; 26(8):1579-1587. PubMed ID: 29472125
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biochemical Evaluation of Lid-Open D-Amino Acid Oxidase Inhibitors.
Szilágyi B; Hargitai C; Kelemen ÁA; Rácz A; Ferenczy GG; Volk B; Keserű GM
Molecules; 2019 Jan; 24(2):. PubMed ID: 30646619
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase.
Raje M; Hin N; Duvall B; Ferraris DV; Berry JF; Thomas AG; Alt J; Rojas C; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2013 Jul; 23(13):3910-3. PubMed ID: 23683589
[TBL] [Abstract][Full Text] [Related]
5. 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors.
Hondo T; Warizaya M; Niimi T; Namatame I; Yamaguchi T; Nakanishi K; Hamajima T; Harada K; Sakashita H; Matsumoto Y; Orita M; Takeuchi M
J Med Chem; 2013 May; 56(9):3582-92. PubMed ID: 23566269
[TBL] [Abstract][Full Text] [Related]
6. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
Szilágyi B; Ferenczy GG; Keserű GM
Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of D-amino acid oxidase inhibitors.
Ferraris D; Duvall B; Ko YS; Thomas AG; Rojas C; Majer P; Hashimoto K; Tsukamoto T
J Med Chem; 2008 Jun; 51(12):3357-9. PubMed ID: 18507366
[TBL] [Abstract][Full Text] [Related]
9. Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.
Szilágyi B; Skok Ž; Rácz A; Frlan R; Ferenczy GG; Ilaš J; Keserű GM
Bioorg Med Chem Lett; 2018 Jun; 28(10):1693-1698. PubMed ID: 29699925
[TBL] [Abstract][Full Text] [Related]
10. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
Sacchi S; Rosini E; Pollegioni L; Molla G
Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
[TBL] [Abstract][Full Text] [Related]
11. Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach.
Reddy MR; Erion MD
J Am Chem Soc; 2001 Jul; 123(26):6246-52. PubMed ID: 11427047
[TBL] [Abstract][Full Text] [Related]
12. D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.
Hin N; Duvall B; Berry JF; Ferraris DV; Rais R; Alt J; Rojas C; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2016 Apr; 26(8):2088-91. PubMed ID: 26965861
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the binding free energies of new TIBO-like HIV-1 reverse transcriptase inhibitors using a combination of PROFEC, PB/SA, CMC/MD, and free energy calculations.
Eriksson MA; Pitera J; Kollman PA
J Med Chem; 1999 Mar; 42(5):868-81. PubMed ID: 10072684
[TBL] [Abstract][Full Text] [Related]
14. Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
Lange JH; Venhorst J; van Dongen MJ; Frankena J; Bassissi F; de Bruin NM; den Besten C; de Beer SB; Oostenbrink C; Markova N; Kruse CG
Eur J Med Chem; 2011 Oct; 46(10):4808-19. PubMed ID: 21880399
[TBL] [Abstract][Full Text] [Related]
15. Rigorous Free Energy Perturbation Approach to Estimating Relative Binding Affinities between Ligands with Multiple Protonation and Tautomeric States.
de Oliveira C; Yu HS; Chen W; Abel R; Wang L
J Chem Theory Comput; 2019 Jan; 15(1):424-435. PubMed ID: 30537823
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
Ferraris DV; Tsukamoto T
Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
[TBL] [Abstract][Full Text] [Related]
17. Interactions of the potent D-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia.
Gong N; Wang YC; Wang HL; Ma AN; Hashimoto K; Wang YX
Neuropharmacology; 2012 Sep; 63(3):460-8. PubMed ID: 22587944
[TBL] [Abstract][Full Text] [Related]
18. Discovery and analgesic evaluation of 8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione as a novel potent d-amino acid oxidase inhibitor.
Xie D; Lu J; Xie J; Cui J; Li TF; Wang YC; Chen Y; Gong N; Li XY; Fu L; Wang YX
Eur J Med Chem; 2016 Jul; 117():19-32. PubMed ID: 27089209
[TBL] [Abstract][Full Text] [Related]
19. 6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors.
Hin N; Duvall B; Ferraris D; Alt J; Thomas AG; Rais R; Rojas C; Wu Y; Wozniak KM; Slusher BS; Tsukamoto T
J Med Chem; 2015 Sep; 58(18):7258-72. PubMed ID: 26309148
[TBL] [Abstract][Full Text] [Related]
20. Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2.
Athanasiou C; Vasilakaki S; Dellis D; Cournia Z
J Comput Aided Mol Des; 2018 Jan; 32(1):21-44. PubMed ID: 29119352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
